67 S T A T. ]
PUBLIC LAW 201-AUG. 5, 1953
389
"(b) Any codification published pursuant to subsection (a) of this section shall be printed and bound in permanent form. As far as practicable, each title in such codification shall constitute a separate book. Each book shall include an index thereto, and a pocket for cumulative supplements. A general index to the entire edition shall be separately printed and bound and shall be provided with a pocket for cumulative supplements. "(c) Cumulative supplements to the codifications may be published annually. Such supplements shall contain the full text of all changes and additions issued since the codification date specified by the Committee which are still in effect. Individual books, including; the cumulative supplements thereto, may be collated and republished when deemed necessary by the Committee. " (d) The Federal Register Division shall prepare, index, and publish the codifications and supplements thereto including the collations as authorized by subsection (c) of this section. "(e) The codified documents of the several agencies published in the supplemental edition of the Federal Register pursuant to the provisions of this section, as amended by documents subsequently filed with the division and published in the daily issues of the Federal Register, shall be prima facie evidence of the text of such documents and of the fact that they are in full force and effect on and after the date of publication. "(f) The Administrative Committee of the Federal Register shall prescribe, with the approval of the President, regulations for carrying out the provisions of this section. "(g) The provisions of this section shall apply to the Code of Federal Regulations, 1949 Edition, authorized by and published pursuant to Executive Order No. 9930 of February 4, 1948." o.i.,^^^n'o ^^"^^ Supp., p. 99. Approved August 5, 1953. Public Law 201
CHAPTER 334
AN ACT To amend sections 502(1) and 507 of the Federal Food, Drug, and Cosmetic Act in order to identify the d r u g linown as aureomycin by its chemical name, chlortetracycline.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, That section 502(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. sec. 352 (1)) is amended by striking out "aureomycin and inserting in lieu thereof "chlortetracycline". SEC. 2. (a) The heading of section 507 of such Act (21 U.S.C. sec. 357) is amended by striking out "AUREOMYCIN" and inserting in lieu thereof "CHLORTETRACYCLINE",
(b) The first sentence of subsection (a) of such section 507 is amended by striking out "aureomycin" and inserting in lieu thereof "chlortetracycline". Approved August 5, 1953.
August 5. 1953 [H. R. 5016]
63 Stat. 409.
�
